AU2005245568A1 - Steroid prodrugs with androgenic effect - Google Patents

Steroid prodrugs with androgenic effect Download PDF

Info

Publication number
AU2005245568A1
AU2005245568A1 AU2005245568A AU2005245568A AU2005245568A1 AU 2005245568 A1 AU2005245568 A1 AU 2005245568A1 AU 2005245568 A AU2005245568 A AU 2005245568A AU 2005245568 A AU2005245568 A AU 2005245568A AU 2005245568 A1 AU2005245568 A1 AU 2005245568A1
Authority
AU
Australia
Prior art keywords
group
sulfamoyl benzoate
oxo
benzoate
sulfamoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2005245568A
Other languages
English (en)
Inventor
Peter Droescher
Walter Elger
Alexander Hillisch
Gudrun Reddersen
Sven Ring
Birgitt Schneider
Ralf Wyrwa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU2005245568A1 publication Critical patent/AU2005245568A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AU2005245568A 2004-05-21 2005-05-10 Steroid prodrugs with androgenic effect Abandoned AU2005245568A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004025986A DE102004025986A1 (de) 2004-05-21 2004-05-21 Steroid-Prodrugs mit androgener Wirkung
DE102004025986.0 2004-05-21
PCT/EP2005/005256 WO2005113575A1 (de) 2004-05-21 2005-05-10 Steroid-prodrugs mit androgener wirkung

Publications (1)

Publication Number Publication Date
AU2005245568A1 true AU2005245568A1 (en) 2005-12-01

Family

ID=34968657

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005245568A Abandoned AU2005245568A1 (en) 2004-05-21 2005-05-10 Steroid prodrugs with androgenic effect

Country Status (22)

Country Link
EP (1) EP1747229A1 (zh)
JP (1) JP2007538026A (zh)
CN (1) CN1993375A (zh)
AR (1) AR049547A1 (zh)
AU (1) AU2005245568A1 (zh)
BR (1) BRPI0510136A (zh)
CA (1) CA2564963A1 (zh)
CR (1) CR8785A (zh)
DE (1) DE102004025986A1 (zh)
EA (1) EA200602049A1 (zh)
EC (1) ECSP067028A (zh)
GT (1) GT200500122A (zh)
IL (1) IL179293A0 (zh)
MX (1) MXPA06013469A (zh)
NO (1) NO20065885L (zh)
PA (1) PA8633601A1 (zh)
PE (1) PE20060271A1 (zh)
SV (1) SV2006002123A (zh)
TW (1) TW200613317A (zh)
UY (1) UY28911A1 (zh)
WO (1) WO2005113575A1 (zh)
ZA (1) ZA200610769B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (de) 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
DE102005057224A1 (de) * 2005-11-29 2007-05-31 Bayer Schering Pharma Ag Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE102005057408A1 (de) * 2005-11-30 2007-05-31 Bayer Schering Pharma Ag Sulfamoylsulfonat-Prodrugs
CN101708338B (zh) * 2008-12-26 2014-06-04 中国人民解放军军事医学科学院放射与辐射医学研究所 含甾体结构的前药及其高度分散制剂
CN102964417A (zh) * 2012-11-30 2013-03-13 华中药业股份有限公司 17-羟基四氢吡喃醚甾族化合物的合成方法
CN107556258B (zh) * 2017-08-22 2021-06-04 湖北江田精密化学有限公司 一种4-氨基-2-氯-5(1h-四唑基-5)苯磺酰胺的制备方法
EP3533619A1 (en) * 2018-03-02 2019-09-04 Basf Se Heat sensitive recording material and color developer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH545316A (de) * 1970-07-17 1973-12-15 Hoffmann La Roche Verfahren zur Herstellung von Acylderivaten
US5001234A (en) * 1987-04-16 1991-03-19 The Upjohn Company Cyclic hydrocarbons with an aminoalkyl sidechain
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
DE19712488A1 (de) * 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
DE10027887A1 (de) * 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
GT200500122A (es) 2006-01-24
ECSP067028A (es) 2006-12-29
CA2564963A1 (en) 2005-12-01
IL179293A0 (en) 2007-03-08
AR049547A1 (es) 2006-08-16
CN1993375A (zh) 2007-07-04
CR8785A (es) 2007-02-05
BRPI0510136A (pt) 2007-10-02
UY28911A1 (es) 2005-12-30
EP1747229A1 (de) 2007-01-31
TW200613317A (en) 2006-05-01
PA8633601A1 (es) 2006-07-03
WO2005113575A1 (de) 2005-12-01
JP2007538026A (ja) 2007-12-27
DE102004025986A1 (de) 2005-12-15
PE20060271A1 (es) 2006-05-25
MXPA06013469A (es) 2007-01-23
EA200602049A1 (ru) 2007-06-29
ZA200610769B (en) 2008-08-27
NO20065885L (no) 2006-12-19
SV2006002123A (es) 2006-02-15

Similar Documents

Publication Publication Date Title
JP6130087B1 (ja) １７−ヒドロキシ−１７−ペンタフルオロエチル−エストラ−４，９（１０）−ジエン−１１−アリール誘導体、その製造方法、その誘導体を利用した諸疾患の治療
KR0181264B1 (ko) 성스테로이드 활성 억제용 안드로겐 유도체
US7534780B2 (en) Estradiol prodrugs
JP5268635B2 (ja) １７β−ＨＳＤ１及びＳＴＳインヒビター
AU2005245568A1 (en) Steroid prodrugs with androgenic effect
US5763432A (en) Steriod inhibitors of estrone sulfatase and associated pharmaceutical compositions and methods of use
AU1941699A (en) Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use
CA2768453A1 (en) 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylene phenyl derivatives, methods for the production thereof and use thereof for treating diseases
BG61978B1 (bg) 16-заместени-4-аза-андростани като инхибитори на изозима 5 алфа-редуктаза 1
US20070197488A1 (en) Prodrugs of ERbeta-selective substances, process for their production, and pharmaceutical compositions that contain these compounds
EP0367576A2 (en) Estrogen nucleus derivatives for use in the inhibition of sex steroid activity
JP2001524487A (ja) アンドロゲンステロイド化合物並びにその調製法及び使用法
MX2012006169A (es) Derivados de estradiol 6-sustituidos y metodos de uso.
JP3820349B2 (ja) エストロンスルファターゼのインヒビターとしてのステロイド３−ｏ−スルファメート誘導体
JP2014094952A (ja) 局所活性「ソフト」抗アンドロゲン剤
JP2001524525A (ja) エストロンスルファターゼのインヒビターとしてのステロイド３−ｏ−スルファメート誘導体
EP1747231A1 (de) Aminosulfonyl- oder aminosulfonylamino-substituierte phenyl-ester als estriol- und estetrol-prodrugs
US20050282793A1 (en) Steroid prodrugs with androgenic action
JP2003513102A (ja) 選択的な作用を有するエストロゲンとしての１８−ノル−ステロイド
TW200938205A (en) 15,16-methylene-17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof and drug containing the derivative
KR20070020454A (ko) 안드로겐 효과를 가지는 스테로이드 프로드러그
AU2006319382A1 (en) Prodrugs of ER-beta-selective substances method for production thereof and pharmaceutical compositions comprising the same

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period